| 10.5 0.09 (0.86%) | 11-02 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Tabula Rasa HealthCare, Inc. (TRHC) is an American healthcare technology company, operating through its CareVention HealthCare and MedWise HealthCare segments. The company develops and delivers a suite of cloud-based software and services aimed at optimizing medication management and improving patient care. Key offerings include EireneRx, an e-prescribing and medication decision-support platform, and MedWise, a medication therapy management (MTM) software designed to help identify and resolve drug-related issues. For precise dosing, they offer DoseMeRx, a decision support tool that leverages pharmacokinetic models and patient data. TRHC also provides comprehensive solutions for Programs of All-Inclusive Care for the Elderly (PACE), such as TruChart for electronic health records (EHR), care coordination, and financial oversight to track outcomes, and PACElogic, which integrates EHR, customer relationship management, claims processing, and care management workflows with regulatory reporting. PrescribeWellness serves as a patient engagement platform. Beyond software, the company offers clinical pharmacist collaboration, prescription fulfillment and adherence packaging, pharmacy benefit management (PBM), and health plan management services, including risk adjustment and third-party administration. As of December 31, 2021, TRHC's technology and services supported approximately 150 healthcare organizations, 350 health plans, and 18,000 retail pharmacies, providing valuable tools for prescribers and pharmacists. Founded in 2009, Tabula Rasa HealthCare, Inc. is headquartered in Moorestown, New Jersey.
Thu, 02 Nov 2023
Tabula Rasa to go private after $570M acquisition - NJBIZ
Tue, 31 Oct 2023
Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners - PR Newswire
Mon, 07 Aug 2023
Tabula Rasa agrees to be acquired in $570M all-cash deal, less than a year after pushing out its founder - The Business Journals
Tue, 11 Oct 2022
TRHC Adds Ron Mitchell to its Board of Directors - citybiz
Mon, 01 Aug 2022
Transaction Data Systems Completes Acquisition of PrescribeWellness - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|